Avestar Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,635	Closed	-$682K	–	497
2023 Q4	$682K	Sell	7,635 -70	-0.9%	-$5.2K	0.08%	162
2023 Q3	$563K	Buy	7,705 +100	+1%	+$7.99K	0.09%	156
2023 Q2	$633K	Sell	7,605 -500	-6%	-$41.8K	0.11%	126
2023 Q1	$618K	Sell	8,105 -265	-3%	-$22K	0.12%	122
2022 Q4	$695K	Sell	8,370 -50	-0.6%	-$4.05K	0.15%	110
2022 Q3	$668K	Buy	8,420 +200	+2%	+$16.9K	0.19%	88
2022 Q2	$610K	Buy	+8,220	New	+$617K	0.17%	103
2018 Q4	–	Sell	-19,505	Closed	-$1.85M	–	1021
2018 Q3	$1.85M	Buy	19,505 +4,255	+28%	+$413K	1.07%	24
2018 Q2	$1.43M	Buy	15,250 +5,810	+62%	+$534K	0.91%	27
2018 Q1	$813K	Buy	9,440 +2,571	+37%	+$235K	0.53%	36
2017 Q4	$578K	Buy	+6,869	New	+$575K	0.43%	35